Definium Therapeutics (DFTX) has had the highest return between May 25, 2026 and July 6, 2026 by a mid-cap US stock, returning 94%.
| ASSET | DATE | % RETURN |
|---|---|---|
Definium Therapeutics (DFTX) | 5/25/2026 - 7/6/2026 | 93.99% |
Sellas Life Sciences (SLS) | 5/25/2026 - 7/6/2026 | 92.05% |
MBX Biosciences, Inc Common Stock (MBX) | 5/25/2026 - 7/6/2026 | 79.39% |
Sezzle (SEZL) | 5/25/2026 - 7/6/2026 | 73.67% |
Uniqure (QURE) | 5/25/2026 - 7/6/2026 | 71.28% |
Butterfly Network (BFLY) | 5/25/2026 - 7/6/2026 | 69.16% |
Biohaven (BHVN) | 5/25/2026 - 7/6/2026 | 68% |
Dave (DAVE) | 5/25/2026 - 7/6/2026 | 67.51% |
Anterix (ATEX) | 5/25/2026 - 7/6/2026 | 62.73% |
Erasca (ERAS) | 5/25/2026 - 7/6/2026 | 62.59% |
Twist Bioscience (TWST) | 5/25/2026 - 7/6/2026 | 62.58% |
10X Genomics (TXG) | 5/25/2026 - 7/6/2026 | 62.41% |
Apogee Therapeutics, Inc Common Stock (APGE) | 5/25/2026 - 7/6/2026 | 61.61% |
Newell Brands (NWL) | 5/25/2026 - 7/6/2026 | 61.16% |
Victoria's Secret (VSCO) | 5/25/2026 - 7/6/2026 | 60.91% |
Magnite (MGNI) | 5/25/2026 - 7/6/2026 | 54.51% |
Hims Hers Health (HIMS) | 5/25/2026 - 7/6/2026 | 54.1% |
Tenable (TENB) | 5/25/2026 - 7/6/2026 | 53.11% |
Abcellera Biologics (ABCL) | 5/25/2026 - 7/6/2026 | 53.02% |
Lifestance Health (LFST) | 5/25/2026 - 7/6/2026 | 51.89% |
Hinge Health (HNGE) | 5/25/2026 - 7/6/2026 | 51.61% |
Adaptive Biotechnologies (ADPT) | 5/25/2026 - 7/6/2026 | 51.36% |
Kardigan, Inc Common Stock (KARD) | 5/25/2026 - 7/6/2026 | 49.85% |
Corcept Therapeutics (CORT) | 5/25/2026 - 7/6/2026 | 49.45% |
Clover Health Investments (CLOV) | 5/25/2026 - 7/6/2026 | 48.8% |
Mid-cap stocks are treated as having a market cap between $2B and $10B.